FXIa-IN-19 dihydrochloride

SI-5652

FXIa-IN-19 dihydrochloride, >98% (HPLC)

CAS No. : [2413219-66-4]

IUPAC Name : Methyl ((5R,9S)-9-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carboxamido)-5-methyl-4-oxo-3-aza-1(4,2)-pyridina-2(1,2)-benzenacyclononaphane-24-yl)carbamate dihydrochloride

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
25MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
100MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
250MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
500MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026

Applications : This is a potent, orally bioavailable pyridine-based macrocyclic FXIa inhibitor. Moreover, this pyridinebased macrocycle, possessing the phenylimidazole carboxamide P1, exhibited excellent selectivity against relevant blood coagulation enzymes and displayed antithrombotic efficacy in a rabbit thrombosis model.

References : Corte R. J. et al.: J. Med. Chem., 63(20), 784-803, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.